FDA advisory panel endorsed Grail's multi-cancer blood test in a split vote
- Grail 近 90 天出现 2 次
- 上一次：1 天前 · FDA advisers are voting on Grail's multicancer blood test as Medicare coverage hangs in the balance
发生了什么
The committee voted 7-2 that Galleri's benefits outweigh its risks, though members split 6-4 on the question of effectiveness
摘要按规则整理自下方来源原文